These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37321056)

  • 21. Elevated serum endothelin-1 is an independent predictor of coronary microvascular dysfunction in non-obstructive territories in patients with coronary artery disease.
    Naya M; Aikawa T; Manabe O; Obara M; Koyanagawa K; Katoh C; Tamaki N
    Heart Vessels; 2021 Jul; 36(7):917-923. PubMed ID: 33484293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of hemodynamic indices of conjunctival microvascular function in patients with coronary microvascular dysfunction.
    Mailey JA; Moore JS; Brennan PF; Jing M; Awuah A; McLaughlin JAD; Nesbit MA; Moore TCB; Spence MS
    Microvasc Res; 2023 May; 147():104480. PubMed ID: 36690270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Targeted Therapies for Coronary Microvascular Dysfunction as Assessed by the Index of Microcirculatory Resistance.
    Xu J; Lo S; Juergens CP; Leung DY
    J Cardiovasc Transl Res; 2021 Apr; 14(2):327-337. PubMed ID: 32710373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial CT perfusion compared with transthoracic Doppler echocardiography in evaluation of the coronary microvascular function: An iPOWER substudy.
    Bechsgaard DF; Hove JD; Michelsen MM; Mygind ND; Pena A; Hansen PR; Hansen HS; Kastrup J; Høst N; Gustafsson I; Prescott E
    Clin Physiol Funct Imaging; 2021 Jan; 41(1):85-94. PubMed ID: 33030280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacotherapy for coronary microvascular dysfunction.
    Ong P; Athanasiadis A; Sechtem U
    Eur Heart J Cardiovasc Pharmacother; 2015 Jan; 1(1):65-71. PubMed ID: 27533969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients.
    Bajaj NS; Osborne MT; Gupta A; Tavakkoli A; Bravo PE; Vita T; Bibbo CF; Hainer J; Dorbala S; Blankstein R; Bhatt DL; Di Carli MF; Taqueti VR
    J Am Coll Cardiol; 2018 Aug; 72(7):707-717. PubMed ID: 30092946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New insights to the potential mechanisms driving coronary flow reserve impairment in Cushing's syndrome: A pilot noninvasive study by transthoracic Doppler echocardiography.
    Tona F; Boscaro M; Barbot M; Maritan L; Famoso G; Dal Lin C; Montisci R; Fallo F; Iliceto S; Scaroni C
    Microvasc Res; 2020 Mar; 128():103940. PubMed ID: 31678361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noninvasive Microvascular Indices Reveal Peripheral Vascular Abnormalities in Patients With Suspected Coronary Microvascular Dysfunction.
    Nardone M; Miner S; McCarthy M; Ardern CI; Edgell H
    Can J Cardiol; 2020 Aug; 36(8):1289-1297. PubMed ID: 32553821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Isolated Coronary Microvascular Dysfunction With Mortality and Major Adverse Cardiac Events: A Systematic Review and Meta-Analysis of Aggregate Data.
    Gdowski MA; Murthy VL; Doering M; Monroy-Gonzalez AG; Slart R; Brown DL
    J Am Heart Assoc; 2020 May; 9(9):e014954. PubMed ID: 32345133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Systematic Approach to the Evaluation of the Coronary Microcirculation Using Bolus Thermodilution: CATH CMD.
    Collet C; Yong A; Munhoz D; Akasaka T; Berry C; Blair JEA; Collison D; Engstrøm T; Escaned J; Fearon WF; Ford T; Gori T; Koo BK; Low AF; Miner S; Ng MKC; Mizukami T; Shimokawa H; Smilowitz NR; Sutton NR; Svanerud J; Tremmel JA; Warisawa T; West NEJ; Ali ZA
    J Soc Cardiovasc Angiogr Interv; 2024 Jul; 3(7):101934. PubMed ID: 39131992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'.
    Padro T; Manfrini O; Bugiardini R; Canty J; Cenko E; De Luca G; Duncker DJ; Eringa EC; Koller A; Tousoulis D; Trifunovic D; Vavlukis M; de Wit C; Badimon L
    Cardiovasc Res; 2020 Mar; 116(4):741-755. PubMed ID: 32034397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary Microvascular Dysfunction Assessed by Pressure Wire and CMR After STEMI Predicts Long-Term Outcomes.
    Scarsini R; Shanmuganathan M; De Maria GL; Borlotti A; Kotronias RA; Burrage MK; Terentes-Printzios D; Langrish J; Lucking A; Fahrni G; Cuculi F; Ribichini F; Choudhury RP; Kharbanda R; Ferreira VM; Channon KM; Banning AP;
    JACC Cardiovasc Imaging; 2021 Oct; 14(10):1948-1959. PubMed ID: 33865789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarkers of Coronary Microvascular Dysfunction in Patients With Microvascular Angina: A Narrative Review.
    Sucato V; Corrado E; Manno G; Amata F; Testa G; Novo G; Galassi AR
    Angiology; 2022 May; 73(5):395-406. PubMed ID: 34338554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Women with coronary microvascular dysfunction and no obstructive coronary artery disease have reduced exercise capacity.
    Bechsgaard DF; Hove JD; Suhrs HE; Bové KB; Shahriari P; Gustafsson I; Prescott E
    Int J Cardiol; 2019 Oct; 293():1-9. PubMed ID: 31345648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronary microvascular dysfunction is associated with cardiac time intervals in women with angina and no obstructive coronary artery disease: An iPOWER substudy.
    Pena A; Michelsen MM; Mygind ND; Gustafsson I; Høst N; Bech J; Kastrup J; Hansen HS; Hansen PR; Prescott E
    Echocardiography; 2019 Jun; 36(6):1110-1117. PubMed ID: 31012159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and characteristics of coronary microvascular dysfunction among chest pain patients in the emergency department.
    Safdar B; D'Onofrio G; Dziura J; Russell RR; Johnson C; Sinusas AJ
    Eur Heart J Acute Cardiovasc Care; 2020 Feb; 9(1):5-13. PubMed ID: 29543037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary microvascular dysfunction is associated with degree of anaemia in end-stage renal disease.
    Radhakrishnan A; Pickup LC; Price AM; Law JP; McGee KC; Fabritz L; Senior R; Steeds RP; Ferro CJ; Townend JN
    BMC Cardiovasc Disord; 2021 Apr; 21(1):211. PubMed ID: 33902440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diseases of the Coronary Microcirculation: Diagnosis and Treatment.
    Ullrich-Daub H; Daub S; Olschewski M; Münzel T; Gori T
    Dtsch Arztebl Int; 2023 Nov; 120(44):739-746. PubMed ID: 37721132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Coronary microvascular dysfunction: mechanisms and clinical outcome].
    Indolfi C; Porto I; Muscoli S; Fedele F; Mancone M
    G Ital Cardiol (Rome); 2022 Jun; 23(6):397-407. PubMed ID: 35674027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment and Treatment for Coronary Microvascular Dysfunction by Contrast Enhanced Ultrasound.
    Zhan J; Zhong L; Wu J
    Front Cardiovasc Med; 2022; 9():899099. PubMed ID: 35795368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.